Browsing by Subject "Multikinase inhibitors"
Now showing items 1-1 of 1
-
Neoadjuvant multikinase inhibitor in patients with locally advanced unresectable thyroid carcinoma
(2019) [Journal article]Background: Papillary thyroid carcinoma (PTC) is the most common and less aggressive thyroid cancer, but some patients may display locally advanced disease. Therapeutic options are limited in these cases, particularly for ...